Members of the Institute of Neurogenetics in collaboration with other members of the “ProtectMove” Consortium (funded by the German Research Foundation, DFG FOR2488) have recently identified a novel modifier of disease severity and cognitive dysfunction in X-linked dystonia-parkinsonism. This study was published in Annals of Neurology, one of the five leading “Clinical Neurology” journals in the world.
